000			01449 a2200373 4500
005			20250513031957.0
264		0	_c19951121
008			199511s 0 0 eng d
022			_a0306-5456
024	7		_a10.1111/j.1471-0528.1995.tb10853.x _2doi
040			_aNLM _beng _cNLM
100	1		_aAston, K
245	0	0	_aProgestogen therapy and prevention of functional ovarian cysts during pituitary desensitisation with GnRH agonists. _h[electronic resource]
260			_bBritish journal of obstetrics and gynaecology _cOct 1995
300			_a835-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Intranasal
650	0	4	_aAdult
650	0	4	_aAntineoplastic Agents, Hormonal _xtherapeutic use
650	0	4	_aBuserelin _xtherapeutic use
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aFollicular Phase _xdrug effects
650	0	4	_aHumans
650	0	4	_aOvarian Cysts _xprevention & control
650	0	4	_aPituitary Gland _xdrug effects
650	0	4	_aProgestins _xtherapeutic use
650	0	4	_aProspective Studies
700	1		_aArthur, I
700	1		_aMasson, G M
700	1		_aJenkins, J M
773	0		_tBritish journal of obstetrics and gynaecology _gvol. 102 _gno. 10 _gp. 835-7
856	4	0	_uhttps://doi.org/10.1111/j.1471-0528.1995.tb10853.x _zAvailable from publisher's website
999			_c7547200 _d7547200